Angi Inc. financials

ANGI CIK 0001705110

Source: EDGAR filings · Built 2026-06-02T02:20:19Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 45.47M 105.45M 46.40M -88.41M -63.70M 135.93M
EBITDA 112.53M 110.54M 75.06M 15.68M 7.21M 89.16M
Working Capital 143.94M 263.41M 228.56M 202.42M 306.56M 744.13M
Net Debt 231.59M 128.72M 201.35M 263.14M 171.94M 18.85M
Gross Margin 95.40% 95.14% 95.40% 80.88% 83.04% 88.20%
Operating Margin 6.35% 1.85% -1.95% -4.29% -4.19% -0.43%
Net Margin 4.25% 3.11% -2.97% -7.25% -4.35% -0.91%
Return on Equity (ROE) 4.73% 3.47% -3.87% -12.21% -6.21% -1.05%
Return on Assets (ROA) 2.61% 2.01% -2.17% -6.71% -3.50% -0.57%
Current Ratio 1.65× 2.14× 1.88× 1.72× 2.10× 4.18×
Debt-to-Equity 0.58× 0.51× 0.54× 0.56× 0.53× 0.65×
Effective Tax Rate 29.90% -83.53% -6.52% 5.70% 31.83% 78.48%
Cash Conversion Ratio 2.40× 4.23× -2.34× -0.21× -0.09× -14.07×
Accruals Ratio -0.04× -0.07× -0.07× -0.08× -0.04× -0.09×
SBC % of Revenue 1.43% 2.93% 3.20% 2.88% 1.74% 5.70%
CapEx Coverage 1.76× 3.09× 1.97× 0.23× 0.09× 3.59×
Free Cash Flow Per Share $0.98 $2.08 $0.92 $-0.18 $-0.13 $0.27

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 13.76× 23.38×
P/FCF 13.21× 7.98× 27.14× 48.37×
FCF Yield 7.57% 12.54% 3.68% 2.07%
EV / EBITDA 7.40× 1.93× 4.36× 92.19× 666.53× 73.97×
P/S 0.58× 0.07× 0.09× 0.67× 2.86× 4.48×
P/B 0.65× 0.08× 0.12× 1.13× 4.08× 5.17×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.03B 1.19B 1.36B 1.76B 1.62B 1.47B
Cost of Revenue 47.44M 57.58M 62.55M 337.40M 274.66M 173.28M
Gross Profit 983.10M 1.13B 1.30B 1.43B 1.34B 1.29B
Research and Development Expense 87.36M 95.36M 96.54M 73.82M 70.93M 68.80M
Operating Income (Loss) 65.41M 21.89M -26.50M -75.62M -67.92M -6.37M
Income Tax Expense (Benefit) 18.70M -16.77M 1.84M -5.39M -29.89M -15.17M
Earnings Per Share, Basic $0.96 $0.72 $-0.81 $-0.26 $-0.14 $-0.01
Weighted Average Number of Shares Outstanding, Basic 45.79M 50.00M 50.59M 503.01M 502.76M 498.16M
Earnings Per Share, Diluted $0.94 $0.71 $-0.81 $-0.26 $-0.14 $-0.01
Weighted Average Number of Shares Outstanding, Diluted 46.45M 50.67M 50.59M 503.01M 502.76M 498.16M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 303.70M 416.43M 364.04M 321.15M 428.14M 812.71M
Assets, Current 366.38M 495.08M 487.22M 484.20M 585.00M 977.81M
Assets 1.68B 1.83B 1.86B 1.91B 2.01B 2.37B
Long-term Debt 712.28M
Liabilities, Current 222.44M 231.68M 258.65M 281.78M 278.44M 233.68M
Long-term Debt, Excluding Current Maturities 497.67M 496.84M 496.05M 495.28M 494.55M 712.28M
Stockholders' Equity Attributable to Parent 927.37M 1.06B 1.04B 1.05B 1.13B 1.27B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 27.07M 6.21M 188.42M
Payments to Acquire Property, Plant, and Equipment 59.60M 50.49M 47.78M 115.48M 69.91M 52.49M
Net Cash Provided by (Used in) Investing Activities -116.09M -45.07M -103.95M
Net Cash Provided by (Used in) Financing Activities -158.34M -53.76M -16.98M -17.23M -345.17M 337.05M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ANGI CIK 0001705110), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MDWD

MEDIWOUND LTD.

TSHA

Taysha Gene Therapies, Inc.

CRVS

Corvus Pharmaceuticals, Inc.